Hydrochlorothiazide chemical structure
Find information on thousands of medical conditions and prescription drugs.

Hydrochlorothiazide

Hydrochlorothiazide (Apo-Hydro®, Aquazide H®, Microzide®, Oretic®), sometimes abbreviated HCT, HCTZ, or HZT is a popular diuretic drug that acts by inhibiting the kidney's ability to retain water. This reduces the volume of the blood, decreasing peripheral vascular resistance. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
Habitrol
Halcion
Haldol
Haloperidol
Halothane
Heparin sodium
Hepsera
Herceptin
Heroin
Hetacillin
Hexachlorophene
Hexal Diclac
Hexal Ranitic
Hexetidine
Hibiclens
Histidine
Hivid
HMS
Hyalgan
Hyaluronidase
Hycodan
Hycomine
Hydralazine
Hydrochlorothiazide
Hydrocodone
Hydrocortisone
Hydromorphone
Hydromox
Hydroxycarbamide
Hydroxychloroquine
Hydroxystilbamidine
Hydroxyzine
Hyoscine
Hypaque
Hytrin
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Activity

Hydrochlorothiazide belongs to the thiazide class of diuretics, acting on the kidney to reduce sodium (Na) reabsorption in the distal convoluted tubule. This reduces the osmotic pressure in the kidney, causing less water to be reabsorbed by the collecting ducts.

Indications

HCT is often used to treat hypertension, congestive heart failure and symptomatic edema. It is effective in diabetes insipidus and is also sometimes used in hypercalciuria.

Hypokalemia, an occasional side-effect, can be usually prevented by potassium supplements or combining hydrochlorothiazide with a potassium-sparing diuretic.

Side effects

  • Hypokalemia
  • Hypomagnesemia
  • Hyperuricemia and gout
  • High blood sugar
  • High cholesterol
  • Headache

Read more at Wikipedia.org


[List your site here Free!]


Ranbaxy Pharmaceuticals
From Drug Store News, 9/26/05

Ranbaxy Pharmaceuticals earlier this month received FDA approval to market benazepril HCl and hydrochlorothiazide tablets, 5 mg/6.25 mg, 10 mg/12.5 mg, 20 mg/12.5 mg and 20 mg/25 mg.

Benazepril is the generic equivalent to Novartis' hypertension treatment Lotensin. Total annual market sales for benazepril were $102.1 million, of which the combination of benazepril HCl and hydrochlorothiazide accounted for $26.2 million, according to IMS Health data Ranbaxy provided for the 12 months ended in June.

COPYRIGHT 2005 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2005 Gale Group

Return to Hydrochlorothiazide
Home Contact Resources Exchange Links ebay